Why the study?
Medium-level microcontrollers capable of edge computing make it possible to implement complete end-to-end wearable solutions for cardiac arrhythmia classification.
An SVM classifier with an RBF kernel implemented on an ARM Cortex-M4 microcontroller can accurately and efficiently detect atrial fibrillation, demonstrating the feasibility of edge computing for wearable arrhythmia detection.
Supports on-device AF detection feasibility; leaves open prospective clinical validation before wearable adoption.
At present, a medium-level microcontroller is capable of performing edge computing and can handle the computation of neural network kernel functions. This makes it possible to implement a complete end-to-end solution incorporating signal acquisition, digital signal processing, and machine learning for the classification of cardiac arrhythmias on a small wearable device. In this work, we describe the design and implementation of several classifiers for atrial fibrillation detection on a general-purpose ARM Cortex-M4 microcontroller. We used the CMSIS-DSP library, which supports Naïve Bayes and Support Vector Machine classifiers, with different kernel functions. We also developed Python scripts to automatically transfer the Python model (trained in Scikit-learn) to the C environment. To train and evaluate the models, we used part of the data from the PhysioNet/Computing in Cardiology Challenge 2020 and performed simple classification of atrial fibrillation based on heart-rate irregularity. The performance of the classifiers was tested on a general-purpose ARM Cortex-M4 microcontroller (STM32WB55RG). Our study reveals that among the tested classifiers, the SVM classifier with RBF kernel function achieves the highest accuracy of 96.9%, sensitivity of 98.4%, and specificity of 95.8%. The execution time of this classifier was 720 μs per recording. We also discuss the advantages of moving computing tasks to edge devices, including increased power efficiency of the system, improved patient data privacy and security, and reduced overall system operation costs. In addition, we highlight a problem with false-positive detection and unclear significance of device-detected atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Żyliński et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: